Presentation and Diagnosis of Primary Biliary Cirrhosis in the 21st Century

Clinics in Liver Disease

Volumn 12, Issue 2, 2008, Pages 243-259

  Kumagi, Teru ^a,b   Onji, Morikazu ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; MITOCHONDRION ANTIBODY;

ABDOMINAL PAIN; ALKALINE PHOSPHATASE BLOOD LEVEL; ASCITES; BIOCHEMISTRY; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FATIGUE; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; JAUNDICE; LABORATORY TEST; LIVER BIOPSY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; PHYSICAL EXAMINATION; PRIMARY BILIARY CIRRHOSIS; PRURITUS; REVIEW; RISK FACTOR; SEROLOGY; SPLENOMEGALY; VARICOSIS;

DIAGNOSTIC IMAGING; FATIGUE; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; OSTEOPOROSIS; PRURITUS; SEX FACTORS;

EID: 43049114939     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2008.02.014     Document Type: Review

References (76)

1. Kaplan M.M., and Gerschwin M.E. Primary biliary cirrhosis. N Engl J Med 353 (2005) 1261-1273
2. Addison T., and Gull W. On a certain affection of the skin-vitiligoidea-plana-tuberosa. Guys Hosp Rep 7 (1851) 265-277
3. Walker J.G., Doniach D., Roitt I.M., et al. Serological tests in diagnosis of primary biliary cirrhosis. Lancet 17 (1965) 827-831
4. Van de Water J., Cooper A., Surh C.D., et al. Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis. N Engl J Med 320 (1989) 1377-1380
5. Myszor M., and James O.F. The epidemiology of primary biliary cirrhosis in north-east England: an increasingly common disease?. Q J Med 75 (1990) 377-385
6. Prince M.I., and James O.F. The epidemiology of primary biliary cirrhosis. Clin Liver Dis 7 (2003) 795-819
7. Sherlock S., and Scheuer P.J. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med 289 (1973) 674-678
8. Long R.G., Scheuer P.J., and Sherlock S. Presentation and course of asymptomatic primary biliary cirrhosis. Gastroenterology 72 (1977) 1204-1207
9. Christensen E., Crowe J., Doniach D., et al. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. Gastroenterology 78 (1980) 236-246
10. James O., Macklon A.F., and Watson A.J. Primary biliary cirrhosis-a revised clinical spectrum. Lancet 1 (1981) 1278-1281
11. Kapelman B., and Schaffner F. The natural history of primary biliary cirrhosis. Semin Liver Dis 1 (1981) 273-281
12. Eriksson S., and Lindgren S. The prevalence and clinical spectrum of primary biliary cirrhosis in a defined population. Scand J Gastroenterol 19 (1984) 971-976
13. Crowe J., Christensen E., Doniach D., et al. Early features of primary biliary cirrhosis: an analysis of 85 patients. Am J Gastroenterol 80 (1985) 466-468
14. Nyberg A., and Lööf L. Primary biliary cirrhosis: clinical features and outcome, with special reference to asymptomatic disease. Scand J Gastroenterol 24 (1989) 57-64
15. Witt-Sullivan H., Heathcote J., Cauch K., et al. The demography of primary biliary cirrhosis in Ontario, Canada. Hepatology 12 (1990) 98-105
16. Mitchison H.C., Lucey M.R., Kelly P.J., et al. Symptom development and prognosis in primary biliary cirrhosis: a study in two centers. Gastroenterology 99 (1990) 778-784
17. Rydning A., Schrumpf E., Abdelnoor M., et al. Factors of prognostic importance in primary biliary cirrhosis. Scand J Gastroenterol 25 (1990) 119-126
18. Mahl T.C., Shockcor W., and Boyer J.L. Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years. J Hepatol 20 (1994) 707-713
19. Invernizzi P., Crosignani A., Battezzati P.M., et al. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology 25 (1997) 1090-1095
20. Springer J., Cauch-Dudek K., O'Rourke K., et al. Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis. Am J Gastroenterol 94 (1999) 47-53
21. Kim W.R., Lindor K.D., Locke III G.R., et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology 119 (2000) 1631-1636
22. Uddenfeldt P., and Danielsson A. Primary biliary cirrhosis: survival of a cohort followed for 10 years. J Intern Med 248 (2000) 292-298
23. Prince M., Chetwynd A., Newman W., et al. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. Gastroenterology 123 (2002) 1044-1051
24. Nakano T., Inoue K., Hirohara J., et al. Long-term prognosis of primary biliary cirrhosis (PBC) in Japan and analysis of the factors of stage progression in asymptomatic PBC (a-PBC). Hepatol Res 22 (2002) 250-260
25. Leuschner U. Primary biliary cirrhosis-presentation and diagnosis. Clin Liver Dis 7 (2003) 741-758
26. Sood S., Gow P.J., Christie J.M., et al. Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations. Gastroenterology 127 (2004) 470-475
27. Wong G.L., Hui A.Y., Wong V.W., et al. A retrospective study on clinical features and prognostic factors of biopsy-proven primary biliary cirrhosis in Chinese patients. Am J Gastroenterol 100 (2005) 2205-2211
28. Delgado J., Sperber A.D., Novack V., et al. The epidemiology of primary biliary cirrhosis in southern Israel. Isr Med Assoc J 7 (2005) 717-721
29. Sarin S.K., Monga R., Sandhu B.S., et al. Primary biliary cirrhosis in India. Hepatobiliary Pancreat Dis Int 5 (2006) 105-109
30. Peters M.G., Di Bisceglie A.M., Kowdley K.V., et al., PUMPS Group. Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States. Hepatology 46 (2007) 769-775
31. Pla X., Vergara M., Gil M., et al. Incidence, prevalence and clinical course of primary biliary cirrhosis in a Spanish community. Eur J Gastroenterol Hepatol 19 (2007) 859-864
32. Wong RK, Lim SG, Wee A, et al. Primary biliary cirrhosis in Singapore: evaluation of demography, prognostic factors and natural course in a multi-ethnic population. J Gastroenterol Hepatol, in press.
33. Speiciene D., Irnius A., Leuschner U., et al. Primary biliary cirrhosis in Lithuania: diagnosis and clinical picture. Med Sci Monit 13 (2007) 299-306
34. Amarapurkar D.N., and Patel N.D. Spectrum of autoimmune liver diseases in western India. J Gastroenterol Hepatol 22 (2007) 2112-2117
35. Laurin J.M., DeSotel C.K., Jorgensen R.A., et al. The natural history of abdominal pain associated with primary biliary cirrhosis. Am J Gastroenterol 89 (1994) 1840-1843
36. Cauch-Dudek K., Abbey S., Stewart D.E., et al. Fatigue in primary biliary cirrhosis. Gut 43 (1998) 705-710
37. Newton J.L., Davidson A., Kerr S., et al. Autonomic dysfunction in primary biliary cirrhosis correlates with fatigue severity. Eur J Gastroenterol Hepatol 19 (2007) 125-132
38. Newton J.L., Gibson G.J., Tomlinson M., et al. Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence. Hepatology 44 (2006) 91-98
39. Selmi C., Gershwin M.E., Lindor K.D., et al. USA PBC Epidemiology Group. Quality of life and everyday activities in patients with primary biliary cirrhosis. Hepatology 20 (2007) 1836-1843
40. Goldblatt J., Taylor P.J., Lipman T., et al. The true impact of fatigue in primary biliary cirrhosis: a population study. Gastroenterology 122 (2002) 1235-1241
41. Prince M.I., James O.F., Holland N.P., et al. Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use. J Hepatol 32 (2000) 368-373
42. Younossi Z.M., Kiwi M.L., Boparai N., et al. Cholestatic liver diseases and health-related quality of life. Am J Gastroenterol 95 (2000) 497-502
43. Colina F., Pinedo F., Solis J.A., et al. Nodular regenerative hyperplasia of the liver in early histological stages of primary biliary cirrhosis. Gastroenterology 102 (1992) 1319-1324
44. Bressler B., Pinto R., El-Ashry D., et al. Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection?. Gut 54 (2005) 407-410
45. Murata Y., Abe M., Furukawa S., et al. Clinical features of symptomatic primary biliary cirrhosis initially complicated with esophageal varices. J Gastroenterol 41 (2006) 1220-1226
46. Suzuki A., Lymp J., Donlinger J., et al. Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis. Clin Gastroenterol Hepatol 5 (2007) 259-264
47. Shibuya A., Tanaka K., Miyakawa H., et al. Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis. Hepatology 35 (2002) 1172-1178
48. Caballería L., Parés A., Castells A., et al. Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-related cirrhosis. Am J Gastroenterol 96 (2001) 1160-1163
49. Kaplan M.M., Elta G.H., Furie B., et al. Fat-soluble vitamin nutriture in primary biliary cirrhosis. Gastroenterology 95 (1988) 787-792
50. Menon K.V., Angulo P., Weston S., et al. Bone disease in primary biliary cirrhosis: independent indicators and rate of progression. J Hepatol 35 (2001) 316-323
51. Guañabens N., Parés A., Ros I., et al. Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis. J Hepatol 42 (2005) 573-577
52. Solaymani-Dodaran M., Card T.R., Aithal G.P., et al. Fracture risk in people with primary biliary cirrhosis: a population-based cohort study. Gastroenterology 131 (2006) 1752-1757
53. Boulton-Jones J.R., Fenn R.M., West J., et al. Fracture risk of women with primary biliary cirrhosis: no increase compared with general population controls. Aliment Pharmacol Ther 20 (2004) 551-557
54. Mattalia A., Quaranta S., Leung P.S., et al. Characterization of antimitochondrial antibodies in health adults. Hepatology 27 (1998) 656-661
55. Metcalf J.V., Mitchison H.C., Palmer J.M., et al. Natural history of early primary biliary cirrhosis. Lancet 23 (1996) 1399-1402
56. Lazaridis K.N., Juran B.D., Boe G.M., et al. Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis. Hepatology 46 (2007) 785-792
57. Haga H., Miyagawa-Hayashino A., Taira K., et al. Histological recurrence of autoimmune liver diseases after living-donor liver transplantation. Hepatol Res 37 (2007) S463-S469
58. Tsuji K., Watanabe Y., Kouno H., et al. A case of latent primary biliary cirrhosis. Hepatol Res 28 (2004) 166-169
59. Nakamura M., Kondo H., Mori T., et al. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 45 (2007) 118-127
60. Prince M.I., Chetwynd A., Craig W.L., et al. Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort. Gut 53 (2004) 865-870
61. Joshi S., Cauch-Dudek K., Heathcote E.J., et al. Antimitochondrial antibody profiles: are they valid prognostic indicators in primary biliary cirrhosis?. Am J Gastroenterol 97 (2002) 999-1002
62. Michieletti P., Wanless I.R., Katz A., et al. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut 35 (1994) 260-265
63. Grantio A., Muratori P., Muratori L., et al. Antinuclear antibodies giving the 'multiple nuclear dots' or the 'rim-like/membranous' patterns: diagnostic accuracy for primary biliary cirrhosis. Aliment Pharmacol Ther 24 (2006) 1575-1583
64. Mackay I.R. Primary biliary cirrhosis showing a high titer of autoantibody; report of a case. N Engl J Med 258 (1958) 185-188
65. Lindgren S., and Eriksson S. IgM in primary biliary cirrhosis. Physicochemical and complement activating properties. J Lab Clin Med 99 (1982) 636-645
66. Blacher A., Federle M.P., and Brancatelli G. Primary biliary cirrhosis: clinical, pathologic, and helical CT findings in 53 patients. Radiology 220 (2001) 329-336
67. Roll J., Boyer J.L., Barry D., et al. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med 308 (1983) 1-7
68. Rubin E., Schaffner F., and Popper H. Primary biliary cirrhosis. Chronic non-suppurative destructive cholangitis. Am J Pathol 46 (1965) 387-407
69. Scheuer P.J. Primary biliary cirrhosis. Proc R Soc Med 60 (1967) 1257-1260
70. Popper H., and Schaffner F. Nonsuppurative destructive chronic cholangitis and chronic hepatitis. In: Popper H., and Schaffner F. (Eds). Progress in liver diseases vol. 3 (1970), Grune & Stratton, Inc., New York 336-354
71. Ludwig J., Dickson E.R., and McDonald G.S. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 379 (1978) 103-112
72. Bedossa P., Dargere D., and Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38 (2003) 1449-1457
73. Kumagi T., and Heathcote J. Primary biliary cirrhosis. Orphanet J Rare Dis 3 (2008) 1
74. Chazouilleres O., Wendum D., Serfaty L., et al. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 28 (1998) 296-301
75. Talwalkar J.A., Keach J.C., Angulo P., et al. Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system. Am J Gastroenterol 97 (2002) 1191-1197
76. Poupon R., Chazouilleres O., Corpechot C., et al. Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis. Hepatology 44 (2006) 85-90